EP1248637A4 - Pharmaceutical composition comprising pectin effective in inhibiting the male reproductive toxicity - Google Patents

Pharmaceutical composition comprising pectin effective in inhibiting the male reproductive toxicity

Info

Publication number
EP1248637A4
EP1248637A4 EP99962539A EP99962539A EP1248637A4 EP 1248637 A4 EP1248637 A4 EP 1248637A4 EP 99962539 A EP99962539 A EP 99962539A EP 99962539 A EP99962539 A EP 99962539A EP 1248637 A4 EP1248637 A4 EP 1248637A4
Authority
EP
European Patent Office
Prior art keywords
pectin
inhibiting
effective
pharmaceutical composition
male reproductive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99962539A
Other languages
German (de)
French (fr)
Other versions
EP1248637A1 (en
Inventor
Kil Nam Kim
Bong Woo Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KOREA NEW SCIENCE TECHNICAL CENTER Ltd
KOREA NEW SCIENCE TECHNICAL CT
Original Assignee
KOREA NEW SCIENCE TECHNICAL CENTER Ltd
KOREA NEW SCIENCE TECHNICAL CT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KOREA NEW SCIENCE TECHNICAL CENTER Ltd, KOREA NEW SCIENCE TECHNICAL CT filed Critical KOREA NEW SCIENCE TECHNICAL CENTER Ltd
Publication of EP1248637A1 publication Critical patent/EP1248637A1/en
Publication of EP1248637A4 publication Critical patent/EP1248637A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732—Pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP99962539A 1999-12-24 1999-12-30 Pharmaceutical composition comprising pectin effective in inhibiting the male reproductive toxicity Withdrawn EP1248637A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR9961538 1999-12-24
KR10-1999-0061538A KR100401456B1 (en) 1999-12-24 1999-12-24 Pharmaceutical composition comprising pectin effective in inhibiting the male reproductive toxicity
PCT/KR1999/000837 WO2001047531A1 (en) 1999-12-24 1999-12-30 Pharmaceutical composition comprising pectin effective in inhibiting the male reproductive toxicity

Publications (2)

Publication Number Publication Date
EP1248637A1 EP1248637A1 (en) 2002-10-16
EP1248637A4 true EP1248637A4 (en) 2003-06-11

Family

ID=19629145

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99962539A Withdrawn EP1248637A4 (en) 1999-12-24 1999-12-30 Pharmaceutical composition comprising pectin effective in inhibiting the male reproductive toxicity

Country Status (7)

Country Link
EP (1) EP1248637A4 (en)
JP (1) JP2003518502A (en)
KR (1) KR100401456B1 (en)
CN (1) CN1398186A (en)
AU (1) AU1895400A (en)
BR (1) BR9917601A (en)
WO (1) WO2001047531A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100401456B1 (en) * 1999-12-24 2003-10-11 (주) 한국신과학 기술센타 Pharmaceutical composition comprising pectin effective in inhibiting the male reproductive toxicity
KR100368936B1 (en) * 2000-10-04 2003-01-24 주식회사 대웅 A Medicine Containing Ursodeoxycholic Acid for Prevention and Treatment of Environmental Hormones
JP2009256364A (en) * 2009-06-24 2009-11-05 Daily Wellness Co Method and composition for improving health state of fertilizing capacity of male and female animal and human
CN108617921A (en) * 2017-03-24 2018-10-09 南京生矶坊生物工程有限公司 A kind of lycopene preparation method cooperateing with ingredient containing pectin etc. and have repair to prostate
CN109142398B (en) * 2018-07-16 2021-02-02 北京林业大学 Method for improving imaging quality of arabidopsis seeds
CN113546092B (en) * 2021-07-29 2023-07-25 南通大学 Application of a gold nanocluster and a drug for reducing the male reproductive toxicity of copper ions

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834442A (en) * 1994-07-07 1998-11-10 Barbara Ann Karmanos Cancer Institute Method for inhibiting cancer metastasis by oral administration of soluble modified citrus pectin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08310923A (en) * 1995-05-19 1996-11-26 Maruzen Pharmaceut Co Ltd Testosterone 5alpha-reductase inhibitor
JPH11209741A (en) * 1998-01-19 1999-08-03 Shigenobu Sakata Agent for eliminating harmful material for natural environment, human, animal and plant and production thereof
KR100340763B1 (en) * 1999-09-21 2002-06-20 김권 Pharmaceutical composition comprising natural phenol and polyphenol for protecting male reproductive system against endocrine disruptor induced damage
KR100401456B1 (en) * 1999-12-24 2003-10-11 (주) 한국신과학 기술센타 Pharmaceutical composition comprising pectin effective in inhibiting the male reproductive toxicity

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834442A (en) * 1994-07-07 1998-11-10 Barbara Ann Karmanos Cancer Institute Method for inhibiting cancer metastasis by oral administration of soluble modified citrus pectin

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HOOPER ET AL: "Workshop on Perintal Exposure to Dioxin-like Compounds", ENVIRONMENTAL HEALTH PERSPECTIVES, vol. 103, no. 2, - 1995, pages 161 - 167, XP009008441 *
See also references of WO0147531A1 *

Also Published As

Publication number Publication date
WO2001047531A1 (en) 2001-07-05
KR20010058066A (en) 2001-07-05
AU1895400A (en) 2001-07-09
CN1398186A (en) 2003-02-19
KR100401456B1 (en) 2003-10-11
JP2003518502A (en) 2003-06-10
EP1248637A1 (en) 2002-10-16
BR9917601A (en) 2005-05-10

Similar Documents

Publication Publication Date Title
IL144977A0 (en) Pyrrolotriazine derivatives and pharmaceutical compositions containing the same
IL152451A0 (en) 2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same
HUP0301178A3 (en) Glucopyranosyloxybenzylbenzene derivatives and pharmaceutical compositions containing the same
IL153123A0 (en) N-ureidoheterocycloalkyl-piperidine derivatives and pharmaceutical compositions containing the same
GB9916536D0 (en) Nutritional or pharmaceutical compositions
ZA200110022B (en) Thiazoloderivatives and pharmaceutical compositions containing them.
HUP0202513A3 (en) Betha-carboline pharmaceutical compositions
PL351387A1 (en) Pharmaceutical composition
IL138899A0 (en) Amidene derivatives and pharmaceutical compositions containing the same
IL206621A0 (en) Caspase inhibitors and pharmaceutical compositions containing the same
IL140862A0 (en) Thiobenzimidazole derivatives and pharmaceutical compositions containing the same
GB0028088D0 (en) Pharmaceutical compositions
GB0001662D0 (en) Pharmaceutical compositions
HUP0103507A3 (en) Pharmaceutical compositions comprising 2-quinolones
IL143920A0 (en) 3-heteroarylidenyl-2-indolinone derivatives and pharmaceutical compositions containing the same
GB9923436D0 (en) Pharmaceutical compositions
IL147214A0 (en) 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same
HUP0200055A3 (en) 16-hydroxyestrienes and pharmaceutical compositions containing the same
GB9904163D0 (en) Pharmaceutical compositions
HUP0104852A3 (en) Oktahydro-pyrido-pyrazine derivatives and pharmaceutical compositions containing the same and their use
MXPA01011309A (en) Compositions containing benzimidazolones and progestogens.
GB9911017D0 (en) Pharmaceutical compositions
HUP0202223A3 (en) Pseudomycin prodrugs, pharmaceutical compositions comprising thereof and their use
AU1895400A (en) Pharmaceutical composition comprising pectin effective in inhibiting the male reproductive toxicity
GB9904911D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020724

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20030429

17Q First examination report despatched

Effective date: 20031120

RBV Designated contracting states (corrected)

Designated state(s): DE FR

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040331